Skip to content

Trevi Therapeutics, Inc. TRVI Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Axcelis Technologies logo
Axcelis TechnologiesACLS
-$39K-106%
PDF Solutions logo
PDF SolutionsPDFS
$0-100%
Fastly, Inc.
 logo
Fastly, Inc. FSLY
$798K+27.5%
Precigen logo
PrecigenPGEN
$369K-47.7%
Varonis Systems logo
Varonis SystemsVRNS
-$882K-791%
Strategic Education, Inc. logo
Strategic Education, Inc.STRA
$3K-96.5%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
Trevi Therapeutics, Inc. (TRVI) reported accretion (amortization) of discounts and premiums, investments of $431K in Q1 2026.
How has Trevi Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
Trevi Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments increased by 9.1% year-over-year, from $395K to $431K.
What is the long-term trend for Trevi Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
Over 2 years (2023 to 2025), Trevi Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a -12.2% compound annual growth rate (CAGR), from $2.13M to $1.64M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to net income resulting from the amortization of premiums or the accretion of discounts on investment securities held by the company. It reflects the gradual adjustment of the carrying value of debt securities toward their par value over the life of the investment. This metric is essential for reconciling net income to cash flow from operations by removing non-cash interest-related income or expense.